A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Not yet recruiting	Phase 2	2025-05-22		NCT06984718

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Akeso	89

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials